The state of oncology care in Russia. Kidney cancer (morbidity, mortality, index of accuracy, one-year and year-by-year mortality, histological structure). Part 1

Background. About 25,000 (2018 - 24,291) new cases of kidney cancer (KC) are registered in Russia annually, in the Northwestern Federal District of Russia in 2018 - 2504.

Kidney cancer refers to localizations with a relatively low mortality rate. Mortality in the first year of observation is about 20 %. At the same time, an unfavorable trend in the dynamics of morbidity should be noted. Over the past 10 years, the annual growth rate for both sexes was 3.18%, mortality practically did not change, which indicates certain success in the treatment of patients.

Materials and methods. The materials of the research were the monographs of IARC “Cancer on five continents”, reference books of the P.A. Herzen Moscow Oncology Research Institute and the database of the population cancer register of the Northwestern Federal District of the Russia own materials. Standard methods of statistical analysis were used.

Results. The study revealed positive trends in the quality of registration of patients with kidney cancer, dynamics of mortality and survival of patients.

Conclusion. The positive dynamics of the incidence rate of the population of Russia with kidney cancer has been established, and its place in the world community has been determined. Age-specific levels are close to those in the United States.

Particular attention is paid to the need to use the Russian population cancer register database to obtain reliable data for an objective assessment of the activities of the oncological service in relation to kidney cancer.

1. Instructional and methodological guidelines for the use of the complete list of tumor morphology codes (ICD-O) and their translation into the codes of the unified system of Population Cancer Registers of Russia. Eds.: O.F. Chepik, V.M. Merabishvili. Saint-Petersburg, 1996. 31 p. (In Russ.).

2. International statistical classification of diseases and related health problems. World Health Organization. Geneva, 1995. 698 p. (In Russ.).

3. Reference book for comparison of ICD-9 and ICD-10 codes by tumor classes. Ed.: V.M. Merabishvili. Saint-Petersburg, 1998. 91 p. (In Russ.).

4. Gusenkova L., Merabishvili V., Lashin V., Lasarevich O. Cancer incidence in Russian Federation, Karelia. Cancer incidence in Five Continents. Vol. XI. Eds.: F. Bray, M. Colombet, L. Mery et al. IARC Sci. Publ. No. 166, Lyon, France, 2021. Pp. 886-887, 1013-1410.

5. Vazhenin A., Domozhirova I., Aksenova T. et al. Cancer incidence in Russian Federation, Chelyabinsk. Cancer incidence in Five Continents. Vol. XI. Eds.: F. Bray, M. Colombet, L. Mery et al. IARC Sci. Publ. No. 166, Lyon, France, 2021. Pp. 884-885, 1013-1410.

6. Cancer Incidence in Five Continents. Vol. XI. IARC Cancer Base No. 14. Eds.: F. Bray, M. Colombet, L. Mery et al. Lyon, 2018.

7. Malignant tumors in Russia in 2018 (morbidity and mortality). Eds.: A.D. Kaprin, V.V. Starinskiy, G.V. Petrova. Moscow: MNIOI im. P.A. Gertsena - filial FGBU “NMITS radiologii” Minzdrava Rossii, 2019. 250 p. (In Russ.).

8. Malignant tumors in Russia in 2010 (morbidity and mortality). Eds.: V.I. Chissov, V.V. Starinskiy, G.V. Petrova. Moscow: MNIOI im. P.A. Gertsena - filial FGBU “NMITS radiologii” Minzdrava Rossii, 2012. 260 p. (In Russ.).

9. Malignant tumors in Russia in 2000 (morbidity and mortality). Eds.: V.I. Chissov, V.V. Starinskiy. Moscow: MNIOI im. P.A. Gertsena - filial FGBU “NMITS radiologii” Minzdrava Rossii, 2002. 264 p. (In Russ.).

10. Malignant tumors in Russia in 2015 (morbidity and mortality). Eds.: A.D. Kaprin, V.V. Starinskiy, G.V. Petrova. Moscow: MNIOI im. P.A. Gertsena - filial FGBU “NMITS radiologii” Minzdrava Rossii, 2017. 250 p. (In Russ.).

11. Malignant tumors in Russia in 2016 (morbidity and mortality). Eds.: A.D. Kaprin, V.V. Starinskiy, G.V. Petrova. Moscow: MNIOI im. P.A. Gertsena - filial FGBU “NMITS radiologii” Minzdrava Rossii, 2018. 250 p. (In Russ.).

12. Malignant tumors in Russia in 2017 (morbidity and mortality). Eds.: A.D. Kaprin, V.V. Starinskiy, G.V. Petrova. Moscow: MNIOI im. P.A. Gertsena - filial FGBU “NMITS radiologii” Minzdrava Rossii, 2018. 250 p. (In Russ.).

13. Merabishvili V.M. Analytical parameters of the index of accuracy. Voprosy onkologii = Problems in Oncology 2018;64(3):445-52. (In Russ.).

14. Merabishvili V.M. Index of accuracy as the most important criterion for objective assessment of cancer care for all types of cancer regardless of mortality rate. Voprosy onkologii = Problems in Oncology 2019;65(4):510-5. (In Russ.).

15. Malignant tumors in Russia in 2019 (morbidity and mortality). Eds.: A.D. Kaprin, V.V. Starinskiy, A.O Shachzadova. Moscow: MNIOI im. P.A. Gertsena -filial FGBU “NMITS radiologii” Minzdrava Rossii, 2020. 214 p. (In Russ.).

16. State of oncological care in Russia in 2019. Eds.: А.1). Kaprin, V.V. Starinskiy, A.O Shachzadova. Moscow: MNIOI im. P.A. Gertsena - filial FGBU “NMITS radiologii” Minzdrava Rossii, 2020. 239 p. (In Russ.).

17. Merabishvili V.M. Malignant tumors in the North-West Federal Region of Russia (morbidity, mortality, index accuracy, survival). Express-information. 5th Issue. Eds: A.M. Belyaev, A.M. Shcherbakov. Saint-Petersburg: T8 Izdatel'skie tekhnologii, 2020. 236 p. [(In Russ.).

18. Merabishvili V.M. Malignant tumors in the North-West Federal Region of Russia (morbidity, mortality, prevalence rate, survival). Express-information. 4th Issue. Ed: A.M. Belyaev. Saint-Petersburg: T8 Izdatel'skie tekhnologii, 2018. 444 p. [(In Russ.).

19. Srigley J.R., Delahunt B., Eble J.N. et al. The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. Am J Surg Pathol 2013;37(10):1469-89. DOI: 10.1097/PAS.0b013e318299f2d1.

20. Humphrey P.A., Moch H., Cubilla A.L. et al. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours. Eur Urol 2016;70(1):106-19. DOI: 10.1016/j.eururo.2016.02.028.